SCHOTTEN; Theo
Patent Applications and Registrations
Patent applications and USPTO patent grants for SCHOTTEN; Theo.The latest application filed is for "zwitterionic nanoparticles".
Company Profile
4.19.19
- SCHOTTEN; Theo - Hamburg DE
- Schotten; Theo - Vierhoefen DE
- Schotten; Theo - Vierhufen DE
- Schotten, Theo - Vierhofen DE
- Schotten; Theo - Vierh ofen DE
Patent Activity
| Patent | Date |
|---|---|
| Zwitterionic Nanoparticles App 20190369107 - SCHOTTEN; Theo ; et al. | 2019-12-05 |
| Zwitterionic Nanoparticles App 20190367807 - HEEREN; Joerg ; et al. | 2019-12-05 |
| Polymer micelles containing nanoparticles in non-aqueous solution, methods for their preparation and use Grant 10,357,751 - Schotten , et al. July 23, 2 | 2019-07-23 |
| Polymer micelles containing nanoparticles in non-aqueous solution, methods for their preparation and use Grant 10,315,178 - Schotten , et al. | 2019-06-11 |
| Polymer Micelles Containing Nanoparticles In Non-aqueous Solution, Methods For Their Preparation And Use App 20170225141 - SCHOTTEN; Theo ; et al. | 2017-08-10 |
| Polymer Micelles Containing Nanoparticles In Non-aqueous Solution, Methods For Their Preparation And Use App 20170225140 - SCHOTTEN; Theo ; et al. | 2017-08-10 |
| .beta..sub.3 adrenergic agonists Grant 7,265,127 - Bastian , et al. September 4, 2 | 2007-09-04 |
| .beta..sub.3 adrenergic agonists Grant 7,253,181 - Bastian , et al. August 7, 2 | 2007-08-07 |
| .beta..sub.3 adrenergic agonists Grant 7,241,772 - Bastian , et al. July 10, 2 | 2007-07-10 |
| Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes Grant 7,229,987 - Ammenn , et al. June 12, 2 | 2007-06-12 |
| .beta.3 adrenergic agonists Grant 7,208,505 - Sall , et al. April 24, 2 | 2007-04-24 |
| 3-Substituted oxindole .beta.3 agonists Grant 7,205,407 - Bastian , et al. April 17, 2 | 2007-04-17 |
| 3-substituted oxindole .beta.3 agonists Grant 7,087,635 - Sall , et al. August 8, 2 | 2006-08-08 |
| .beta..sub.3 Adrenergic agonists Grant 7,071,208 - Bastian , et al. July 4, 2 | 2006-07-04 |
| Beta 3 Adrenergic Agonists App 20060142328 - Bastian; Jolie Anne ; et al. | 2006-06-29 |
| Beta 3 Adrenergic Agonists App 20060142327 - Bastian; Jolie Anne ; et al. | 2006-06-29 |
| Beta 3 Adrenergic Agonists App 20060142329 - Bastian; Jolie Anne ; et al. | 2006-06-29 |
| Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes App 20050272718 - Ammenn, Jochen ; et al. | 2005-12-08 |
| 3-Substituted oxindole beta3 agonists App 20050159473 - Sall, Daniel Jon ; et al. | 2005-07-21 |
| 3-substituted oxindole .beta.-3 agonists Grant 6,911,463 - Sall , et al. June 28, 2 | 2005-06-28 |
| Beta 3 adrenergic agonists App 20050080110 - Sall, Daniel Jon ; et al. | 2005-04-14 |
| Beta 3 adrenergic agonists App 20050020618 - Bastian, Jolie Anne ; et al. | 2005-01-27 |
| 3-substituted oxindole beta3 agonists App 20050020617 - Bastian, Jolie Anne ; et al. | 2005-01-27 |
| Beta3 adrenergic agonists App 20040242633 - Evers, Britta ; et al. | 2004-12-02 |
| 3-substituted oxindole beta-3 agonists App 20040242668 - Sall, Daniel Jon ; et al. | 2004-12-02 |
| Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation Grant 6,693,109 - Fisher , et al. February 17, 2 | 2004-02-17 |
| Methods for producing amino-substituted chromanes App 20040014804 - Antoine, Luc ; et al. | 2004-01-22 |
| Hypoglycemic imidazoline compounds App 20040009976 - Takeuchi, Kumiko ; et al. | 2004-01-15 |
| Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation App 20030171373 - Fisher, Matthew J. ; et al. | 2003-09-11 |
| Glycoprotein llb/llla antagonists App 20030130342 - Fisher, Matthew J. ; et al. | 2003-07-10 |
| Spiro compounds as inhibitors of fibrinogen-dependent platelet aggregation App 20020013325 - Fisher, Matthew J. ; et al. | 2002-01-31 |
| Protein kinase C inhibitors Grant 5,672,618 - Heath, Jr. , et al. September 30, 1 | 1997-09-30 |
| Protein kinase C inhibitors Grant 5,668,152 - Heath, Jr. , et al. September 16, 1 | 1997-09-16 |
| Pyrimidine compounds and their use as pharmaceuticals Grant 5,602,136 - R uhter , et al. February 11, 1 | 1997-02-11 |
| Pyrimidine compounds and their use as pharmaceuticals Grant 5,602,137 - R uhter , et al. February 11, 1 | 1997-02-11 |
| Fused pyrimidine compounds and their use as pharmaceuticals Grant 5,571,813 - R uhter , et al. November 5, 1 | 1996-11-05 |
| Protein kinase C inhibitors Grant 5,545,636 - Heath, Jr. , et al. August 13, 1 | 1996-08-13 |
| Novel benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds Grant 5,028,711 - Stenzel , et al. July 2, 1 | 1991-07-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 